Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus Genotype 1”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01188772
What this trial is testing

Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients

Who this might be right for
Hepatitis C Virus
Gilead Sciences 147
Large-scale testing (Phase 3)Study completedNCT00708500
What this trial is testing

Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 404
Early research (Phase 1)Study completedNCT02339207
What this trial is testing

First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis C
Alios Biopharma Inc. 112
Large-scale testing (Phase 3)Study completedNCT00211692
What this trial is testing

Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial

Who this might be right for
Chronic Hepatitis C
Minneapolis Veterans Affairs Medical Center 64
Testing effectiveness (Phase 2)Study completedNCT01226446
What this trial is testing

Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders

Who this might be right for
Chronic Hepatitis C
French National Agency for Research on AIDS and Viral Hepatitis 32
Post-approval studies (Phase 4)Study completedNCT02759861
What this trial is testing

Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics

Who this might be right for
Genotype 1 Hepatitis C Virus
University of Nebraska 16
Testing effectiveness (Phase 2)Study completedNCT01482403
What this trial is testing

Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 58
Testing effectiveness (Phase 2)Study completedNCT00663208
What this trial is testing

A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 167
Early research (Phase 1)Study completedNCT00801255
What this trial is testing

Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 88
Large-scale testing (Phase 3)Study completedNCT01318694
What this trial is testing

Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants

Who this might be right for
Hepatitis C
Debiopharm International SA 1,081
Post-approval studies (Phase 4)UnknownNCT01731301
What this trial is testing

A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)

Who this might be right for
Chronic Hepatitis CEnd Stage Renal Disease
Liver Institute of Virginia 20
Post-approval studies (Phase 4)Ended earlyNCT00274495
What this trial is testing

Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver

Who this might be right for
Chronic Hepatitis C InfectionFatty Liver
Beth Israel Medical Center 30
Not applicableStudy completedNCT00709228
What this trial is testing

Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 496
Not applicableStudy completedNCT01416610
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 88
Large-scale testing (Phase 3)Study completedNCT00703118
What this trial is testing

A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 663
Testing effectiveness (Phase 2)Study completedNCT00991289
What this trial is testing

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Who this might be right for
HIV InfectionHepatitis C Infection
National Institute of Allergy and Infectious Diseases (NIAID) 68
Not applicableStudy completedNCT02452814
What this trial is testing

Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection

Who this might be right for
HCV
Hoffmann-La Roche 8
Post-approval studies (Phase 4)Study completedNCT02498015
What this trial is testing

A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 87
Not applicableStudy completedNCT02581189
What this trial is testing

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada

Who this might be right for
Chronic Hepatitis C
AbbVie 565
Post-approval studies (Phase 4)Study completedNCT00926614
What this trial is testing

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Who this might be right for
Hepatitis c
Brooke Army Medical Center 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation